1. Binding and suppressive activity of human recombinant ferritins on erythroid cells.
- Author
-
Fargion S, Cappellini MD, Fracanzani AL, De Feo TM, Levi S, Arosio P, and Fiorelli G
- Subjects
- Binding Sites, Cell Differentiation drug effects, Cell Differentiation physiology, Cell Division drug effects, Cell Division physiology, Cells, Cultured, Erythrocytes metabolism, Erythroid Precursor Cells metabolism, Erythroid Precursor Cells physiology, Erythropoiesis drug effects, Ferritins metabolism, Fetal Blood cytology, Humans, Leukemia, Erythroblastic, Acute metabolism, Leukemia, Erythroblastic, Acute pathology, Protein Binding drug effects, Recombinant Proteins pharmacology, Reticulocytes metabolism, Tumor Cells, Cultured metabolism, Tumor Cells, Cultured pathology, Erythroid Precursor Cells drug effects, Ferritins pharmacology
- Abstract
We studied the relation between ferritin cellular binding and suppressive activity of recombinant H- and L-ferritin on human erythroid cells at different proliferation/differentiation phases. L-ferritin failed to show any suppressive activity or detectable binding to erythroblasts at any stage of maturation. In contrast, H-ferritin demonstrated binding to erythroblasts derived from peripheral BFU-E cells which increased steadily between 7-14 days of culture up to 15,000 molecules per cell. Reticulocytes and erythrocytes failed to bind either L- or H-ferritin. H-ferritin suppressed BFU-E colony formation and reduced K562 cell proliferation at nanomolar concentrations. This suggests that the expression of H-ferritin binding sites is modulated by cellular proliferation and differentiation, that cells expressing H-ferritin binding sites are sensitive to ferritin suppressive activity and that a causal relation exists between ferritin cellular binding and suppressive activity.
- Published
- 1992
- Full Text
- View/download PDF